Citigroup reduced and set price target for Stryker, while Truist Financial lifted its target price, with MarketBeat providing consensus data.
1 report, 1 independent
Updated Aug 1
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup reduced and set price target for Stryker, while Truist Financial lifted its target price, with MarketBeat providing consensus data.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Stryker Corporation
American medical technologies company
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- Citigroup and Truist Financial issued buy ratings and increased price targets for Cisco.
- Citigroup and Royal Bank of Canada raised price targets and ratings for a company, with MarketBeat aggregating the financial data.
- MarketBeat reports consensus rating, Citigroup restates a market outperform rating, and Jefferies Financial Group sets a $28.00 target price for Four Corners Property Trust.
- Citigroup and Raymond James Financial issued rating reports and price targets for Marathon Petroleum, which also filed disclosures with the SEC.
- Citigroup provided a rating, Truist Financial boosted the price target, and MarketBeat aggregated consensus data for AMN stock.